J. van Breugel
Please Note
2 records found
1
Corrigendum to bioprocess intensification
Cases that (don't) work (New BIOTECHNOLOGY (2021) 61 (108–115), (S1871678420301965), (10.1016/j.nbt.2020.11.007))
Table 2 in printed publication was miss-set, and should read as follows: [Table presented] The authors would like to apologize for any inconvenience caused.
Bioprocess intensification
Cases that (don't) work
Development of affordable and low carbon biobased manufacturing depends critically on strategies that reduce cost and emission profiles. This paper indicates that efforts around the reduction of capital costs by intensification of process equipment need to be carefully weighed against the inherently fast increasing financial and climate costs of driving forces used for the intensification. The fundamental relation between capital expenditures (CAPEX) and operational expenditures (OPEX) of intensified and non-intensified biobased processes and their financial and climatic impacts are emphasized and provisionally explored for a few industrial processes. General learnings flag the importance in particular of OPEX minimisation for sustainable bio-economic development.